Application of Near Infrared Spectroscopy, Intravascular Ultrasound and the Coronary Calcium Score to Predict Adverse Coronary Events.

摘要

Final IRB approval was granted effective July 15, 2013. Patient screening, enrollment and data acquisition is ongoing. Additional co-investigators have been added to the study including James Smith, MD, Vasco Marques, MD, Mohammed Tabesh, MD, Jordan Hopkins, MD, Asad Sawar, MD, Alex Michel, MD, Faisal Shaikh, MD and Hesham Fakhri, MD. 79 patients have been screened for the study. 24 patients were subsequent screen failures. Thirteen patients have completed enrollment and imaging. One SAE, unrelated to the study, was reported to the IRB. Study operation continues as planned.